Silencing of SUMO-1 via small interfering RNA (siRNA) significantly reduces the migratory and invasive capacities of RA-FLSs, as well as the expression of matrix metalloproteinases MMP-1 and MMP-3. The gene discussed is MMP3; the disease is rheumatoid arthritis.